#leqembi — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #leqembi, aggregated by home.social.
-
Lees tip -> Zorginstituut: lecanemab geen meerwaarde bij Alzheimer | Lecanemab vertraagt Alzheimer nauwelijks, kent risico’s en wordt daarom niet geadviseerd voor vergoeding. | #Alzheimer #basispakket #lecanemab #Leqembi #ZorginstituutNederland |
https://hbpmedia.nl/zorginstituut-lecanemab-geen-meerwaarde-bij-alzheimer/
-
Ein Medikament zum Vergessen.
»Leqembi kann #Alzheimer weder stoppen noch heilen.«
Viele Menschen mit Alzheimer haben auf #Leqembi gehofft, das Medikament ist in den USA bereits erhältlich. Doch die Europäische Arzneimittel-Agentur sieht von einer Zulassung ab.
-
2/2
The United States, Israel, and several Asian countries have approved #Leqembi, but on 26 July the European Medicines Agency announced its benefit in clinical trials was small and does not counterbalance the risk of serious harm. The decision comes weeks after the U.S. Food and Drug Administration approved a second antiamyloid antibody with a similar profile, #donanemab, and as Leqembi’s popularity is growing in the United States.Science, 2 August 2024
-
European drug regulators have withheld approval for a new #Alzheimer’s disease therapy, underscoring deep divisions about a treatment that’s generating both excitement and concern. Infusions of the monoclonal antibody, marketed as #Leqembi by the companies Eisai and Biogen, help clear a toxic protein called beta amyloid from the brain and modestly slow progression of the fatal disease. But the drug comes with considerable risks, including brain swelling and bleeding.
1/2
Science, 2 August 2024 -
European Medicines Agency approves 14 new medicines but rejects new Alzheimer’s drug https://www.euractiv.com/section/health-consumers/news/european-medicines-agency-approves-14-new-medicines-but-rejects-new-alzheimers-drug/?utm_source=dlvr.it&utm_medium=mastodon #AlzheimersDisease #Biogen #Eisai #Leqembi #novonordisk
-
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use. https://www.japantimes.co.jp/news/2024/04/24/world/science-health/alzheimer-drug-us-adoption-slow/ #worldnews #sciencehealth #alzheimers #brain #eisai #biogen #leqembi #us
-
"I think one of the reasons Leqembi was approved (and Lilly's donanemab is likely to be, this year) is that aducanumab was approved. I remain skeptical that these drugs will provide any real-world benefit, but I am not skeptical at all of the sales potentials for both of them."
#Alzheimer
#Leqembi
#aducanumabhttps://www.science.org/content/blog-post/goodbye-aduhelm?s=09
-
Dilemma: Will Leqembi ™ prolong quality of life, or more suffering?
"When FDA approves a new cancer agent, oncologists usually ask: will it prolong duration of good quality life, or just prolong duration of suffering, and will the side effects profile be tolerable enough whether it works or not?
"Those kinds of questions seem pertinent to the new Alzheimer’s Disease (AD) medication, lecanemab, marketed now as Leqembi ™. "
#alzheimer #lecanemab #leqembi
https://caregivingoldguy.website/2023/08/07/dilemma-will-leqembi-tm-prolong-quality-of-life-or-more-suffering/ -
The US Food and Drug Administration has given full approval for a drug they say can slow the progression of Alzheimer's disease.The incurable neurological di...
US government approves Alzheimer’s drug to slow cognitive decline -
The next big thing in Alzheimer’s treatment didn’t reverse symptoms in any trial participants. It’s expensive. And, critics say, it will deepen racial disparities in care for Black patients.
#Alzheimers #leqembi #HealthDisparities -
-
FDA gives full approval to #Leqembi drug for #Alzheimers #dementia. But it offers modest benefits and there are serious side effects. Is this a smart decision? I’m not smart enough to answer that question, but it’s a good question.
https://www.nytimes.com/2023/07/06/health/alzheimers-leqembi-medicare.html
-
Interesting opinion piece about #FDA approach to drug approval, in this case #Leqembi for #Alzheimer's. https://www.washingtonpost.com/opinions/2023/06/15/fda-conditional-approval-alzheimers-drug-leqembi/ (paywalled)
-
Interesting opinion piece about #FDA approach to drug approval, in this case #Leqembi for #Alzheimer's. https://www.washingtonpost.com/opinions/2023/06/15/fda-conditional-approval-alzheimers-drug-leqembi/ (paywalled)
-
is it too skeptical of me to assume Lecanemab/leqembi by biogen/Eisai will show reduced brain volume for people on the drug (just like Phase 2 showed)? #lecanemab #leqembi
-
"#Demenz: US-Arzneibehörde lässt Medikament zur Behandlung von Alzheimer zu"
"Das Medikament #Leqembi soll das Fortschreiten von #Alzheimer deutlich verlangsamen. Es wurde nun im Eilverfahren in den #USA zugelassen, soll aber weiter getestet werden."
:mastoread:
https://www.zeit.de/gesundheit/2023-01/alzheimer-therapie-arzneibehoerde-fda-medikament-zulassung -
US-FDA grants accelerated approval for #lecanemab for patients with early #Alzheimers. The drug, to be sold as #Leqembi, will cost $26'000 per patient and year. "@US_FDA warns about brain swelling and bleeding on Lecamemab drug’s label, but imposes few restrictions on lecanemab’s use"
-
Breaking: #FDA approves Eisai-Biogen #Alzheimer's #ALZ drug #Leqembi, also known as #lecanemab: https://www.statnews.com/2023/01/06/fda-approves-alzheimers-drug-leqembi-eisai/
